Royalty Pharma Plc (RPRX) — Free Cash Flow Generation Index

Latest as of March 2026: 1.00x

Royalty Pharma Plc (RPRX) has a Free Cash Flow Generation Index of 1.00x as of March 2026. Free cash flow of $760.54 Million represents 1% of operating cash flow ($760.54 Million). See how liquid is Royalty Pharma Plc's working capital to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$760.54 Million
USD

Operating Cash Flow

$760.54 Million
USD

Capital Expenditures

$0.00
USD

Royalty Pharma Plc Free Cash Flow Generation Index (2002–2025)

Historical FCF Generation Index trend for Royalty Pharma Plc across 11 annual periods. Explore RPRX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Royalty Pharma Plc (2002–2025)

Year-by-year Free Cash Flow Generation Index for Royalty Pharma Plc. For the full company profile including market capitalisation, see RPRX market cap.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 1.00x $2.49 Billion $2.49 Billion $0.00 ▲ +0.0%
2024 1.00x $2.77 Billion $2.77 Billion $0.00 ▲ +0.0%
2023 1.00x $2.99 Billion $2.99 Billion $2.12 Billion ▼ -48.8%
2022 1.95x $4.19 Billion $2.14 Billion $2.04 Billion ▲ +95.2%
2021 1.00x $2.02 Billion $2.02 Billion $523.00K ▼ -51.9%
2020 2.08x $4.23 Billion $2.03 Billion $2.20 Billion ▲ +108.0%
2019 1.00x $1.67 Billion $1.67 Billion $1.72 Billion ▲ +0.0%
2018 1.00x $1.62 Billion $1.62 Billion $269.59 Million ▲ +0.0%
2017 1.00x $1.42 Billion $1.42 Billion $2.29 Billion ▲ +0.0%
2003 1.00x $11.15 Million $11.15 Million $0.00 ▼ -0.6%
2002 1.01x $8.49 Million $8.45 Million $49.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).